Laboratories can use these templates to notify relevant clinicians of a presumed positive blood spot screening result for cystic fibrosis (CF). Category: UncategorisedBy 17 August 2021Leave a commentPost navigationPreviousPrevious post:Research: COVID-19: impact on vaccination programmesNextNext post:Research: Notifiable diseases: last 52 weeks
